This judgment is being handed down in private on 2 November. It consists of 10 pages and has been signed and dated by the judge. The judge hereby gives leave for it to be reported.
The judgment is being distributed on the strict understanding that in any report no person other than the advocates or the solicitors instructing them (and other persons identified by name in the judgment itself) may be identified by name or location and that in particular the anonymity of the children and the adult members of their family must be strictly preserved.
COURT OF PROTECTION
FAMILY DIVISION
Strand, London, WC2A 2LL |
||
B e f o r e :
THE PRESIDENT OF THE FAMILY DIVISION
____________________
Re AVS |
Applicant |
|
- and - |
||
A NHS Foundation Trust |
Respondent |
____________________
Fenella Morris (instructed by Hempsons) for the Respondent
Hearing dates: 25 October 2010
____________________
Crown Copyright ©
Sir Nicholas Wall P :
Introduction
The Facts and the issue in the case
"From June 2008 (AVS) has received Pentosan Polysulphate (PPS) by way of intraventricular infusion. He has received no PPS since around 26 August 2010 when the infusion pump malfunctioned. Clinicians at (the hospital) have concluded that it is not in AVS's best interests to continue administering PPS and that the infusion pump should not be replaced.
The Court is asked to decide, as a matter of urgency, whether it is in the best interests of AVS:
to undergo surgery to replace the infusion pump; and
for the administration of PPS to continue thereafter."
The way CS puts the case
There is evidence to indicate that the administration of PPS to patients suffering from CJD slows and / or halts the progress of the disease and / or prolongs life……. there is no evidence to suggest that there are any adverse side effects from the administration of PPS but evidence of improvement in condition.
At the time of diagnosis in May 2008, the prognosis for (AVS) was that he was unlikely to survived more than 3 to 4 weeks. He had in fact survived two and a half years since diagnosis. He received PPS from June 2008 until the infusion pump malfunctioned. The administration of PPS is therefore very likely to be the reason why the progress of the disease has been slowed and / or halted, and (AVS's) life lengthened. The continued administration of PPS is therefore likely to to be beneficial to (AVS) and is most unlikely to be detrimental to his welfare. The application is urgent since discontinuing the delivery of PPS for more than a few weeks is expected to result in increased damage and death of previously functioning cells.
Should CS be AVS's next friend in the proceedings?
(1) he talks in paragraph 23 of his first statement of being "generally treated with hostility" by the hospital when he and his family wished to proceed with the administration of PPS; with the consequence that the procedure had to be carried out by a clinician outside the hospital in Scotland;
(2) he accuses Dr DH of misleading him over the reasons for the malfunctioning of the pump;
(3) he accuses Dr DH of being "wrong and misleading" in telling him that PPS remained within the device and was still being infused as at 28 July 2010;
(4) he accuses Dr DH of "inaccuracy" in the content of an Email sent by Dr DH to CS on 29 July 2010 and of exposing AVS to "risk";
(5) he talks of Dr DH's failure to make "any attempt to apologise" for the events which have taken place.
(1) A slight movement of the lips at an attempted grin, groan or grimace or movement of the head or eyes in which we perceive to be the acknowledgement of a comment is more wonderful than any words will allow me to express (first statement paragraph 86); and
(2) [talking of the devoted support given by members of this family] I believe that such support by my family has added to my brother's comfort and general quality of life despite all the adversity that my brother and my family have encountered at (the hospital) which is, regrettably, continuing (ibid, para 87).
The position of the trust
The evidence assembled by CS
(1) two statements by himself, with exhibits, to which I have already made extensive reference. CS is, of course, a solicitor, not a doctor;
(2) a statement by Dr MC, the general practitioner to a different, variant CJD sufferer;
(3) a statement by the father of Dr MC's patient;
(4) a statement by Professor IB, a consultant neurologist;
(5) a statement from Dr CP, a research neurophysiologist;
(6) an "expert opinion" from Dr. NR, a Professor of Surgery from Augsburg;
(7) a medical report from Mr. NT, a consultant neuro-surgeon; and
(8) a letter from Dr SW, a consultant neurologist.
(1) CS wished to adduce the evidence of one of the Trust's nurses, whose identity was not revealed and who would be likely to appear by means of a witness summons; and
(2) Dr P, a consultant neurologist, had written a letter and was prepared to take over AVS's case.
The future of the proceedings
Directions
Disclosure
Postscript